The charity will adopt Ideagen’s Q-Pulse and PleaseReview applications for quality management and document review and collaboration
Ideagen has secured a new project with a leading cancer charity which will see the company supply it with two of its software applications.
The project will see the charity adopt Ideagen’s software for general quality and compliance management tasks as well as for use during complex document review and collaboration projects.
PleaseReview will initially be used by Cancer Research UK’s medical writing and technology teams during comprehensive collaboration and reviews of technical documentation.
Q-Pulse will be adopted by the organisation’s clinical trial and drug production teams, again replacing a manual process for simpler compliance with regulatory bodies such as MHRA.
Sue Waller, Head of Quality, Regulatory and Pharmacovigilance at Cancer Research UK (pictured above), said: “Our ambition is to accelerate progress so that by 2034, three in four people will survive their cancer for at least ten years. To do this, we need to work efficiently and collaboratively and Ideagen’s software will help us do this.
“Using PleaseReview, we will reduce review times across important documentation such as technical processes, drug development documentation or reports.
“Q-Pulse will become our central electronic quality management system, reducing efforts in managing our QMS while improving regulatory compliance and reducing the risk of inspection findings.
“Both software applications will help us continue our pioneering work into the prevention, diagnosis and treatment of cancer.”
Q-Pulse, Ideagen’s flagship quality management product, helps organisations eliminate bureaucracy, automate and streamline business processes for standards and regulatory compliance, safety management and risk management. It is used by more than 2,000 organisations globally.
PleaseReview, the document review, co-authoring and redaction software application, helps to control and manage all aspects of the document creation and review process.
Ideagen provides software and services to organisations operating within highly regulated industries such as aviation, banking and finance, life science, healthcare and manufacturing with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.
Currently, more than 4,700 organisations use Ideagen's products including 75% of the world's leading pharmaceutical firms, 200 life science organisations globally and more than 180 hospitals across the UK and US.